AzurRx BioPharma Announces $3.0 Million Bought Deal Offering of Common Stock
22 juil. 2021 16h51 HE
|
AzurRx BioPharma, Inc.
BOCA RATON, Fla., July 22, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of...